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BACKGROUND

DISCUSSION

•	Adrenal incidentalomas are masses 1cm or greater, identified incidentally on imaging performed for
indications other than for an evaluation of adrenal disease.
•	The incidence of adrenal incidentalomas ranges between 0.5-4 % and the frequency of adrenal
cancers among incidentalomas is extremely small with an estimated prevalence of 4–12 per million
1-2
population.
•	Adrenocortical carcinomas are extremely aggressive tumors and are mostly fatal if not identified early
in the disease course.

CASE PRESENTATION
•	A 24-year-old male presented with 4-month history of facial flushing, weight gain, abdominal pain,
increasing abdominal girth and significant hypertension.
•	Physical exam showed cushingoid facies with facial plethora, abdominal distention and associated
tenderness.
•	Patient noted a history of hospitalization 7-months ago for a motor vehicle accident. CT scan ruled out
internal trauma but revealed a right adrenal incidentaloma measuring 3cm x 2.6cm x 3cm (Figure A).
The patient was discharged and unfortunately lost to follow up.
•	A CT scan done during current admission showed the right adrenal mass increased in size to 8.9cm
x9.1cmx 6cm (Figure B).
•	A comprehensive endocrine work up showed the mass to be functional with overall findings consistant
with cushing syndrome (Table 1).
•	He further underwent right adrenalectomy with pathology confirming high grade adrenocortical
carcinoma with clinical stage II, T2 N0 M0.
Table 1.
•	Despite surgery and aggressive adjuvant chemotherapy, cancer
Reference
Lab
Result
Values
progressed rapidly in 6 months to reach a massive size (Figure
33 ug / dL
4.3 - 22.4 ug / dL
Cortisol level
C and D).
ACTH
<10 pg / mL
10 - 60 pg / mL
24 hour urine cortisol
4796 ug / 24 hours
3.5 - 45 ug / 24 hr
•	The patient survived only 7 months after initial chemotherapy.
Plasma metanephrine

Normal

Plasma normetanephrine

Normal

Serum aldosterone level

Normal

•	The diagnosis of adrenal carcinomas can easily be overlooked in incidentalomas of a young patient population,
partly due to its rarity and partly due to the subclinical nature of the disease at early stages.
•	There is lack of data on the true incidence of adrenal carcinoma in incidentalomas of young.
•	There is high prevalence of benign adrenal cortical adenomas in incidentalomas with increasing age; hence the
finding of an adrenal mass of any size in a young patient should increase the suspicion for malignant potential of
the mass.2
•	Features suggesting malignancy include irregular or unclear margins, heterogeneity with mixed densities,
attenuation (density) > 10 Hounsfield unit (HU) on unenhanced CT scan with rapidity of washout of contrast
medium < 50 % at 10 minutes and hyper intense lesion in relation to liver on T2 weighted imaging on MRI.
•	Though most authors suspect malignancy in masses above 4 cm and recommend resection, the validity of that
threshold is questionable in a much younger population. Adrenal cancer and metastatic cancers are the most
difficult to diagnose especially at an early stage as they can often mimic adenomas in appearance at smaller
sizes.6,7
•	As per AACE and AAES Guidelines, patients with adrenal incidentalomas smaller than 4 cm and radiologic
characteristics consistent with a benign adenoma need to have radiographic reevaluation at 3 to 6 months and
then annually for 1 to 2 years. Hormonal evaluation should be performed at the time of diagnosis and then annually
for up to 5 years. AACE - American Association of Clinical Endocrinologists, AAES - American Association of
Endocrine Surgeons.
•	These guidelines are largely based on a patient population with a median age of 60 years (range 34–79).10,11
•	5% of the patient population with adrenal incidentaloma can have subclinical cushing syndrome, which would
require work up with 1-mg dexamethasone suppression test or urine free cortisol in addition to other routine
hormonal work up.
•	In a much younger population, a lower size threshold and a prompt initial diagnostic work up with a
multidisciplinary approach involving an experienced radiologist, endocrinologist, a surgeon and a pathologist is
warranted.

CONCLUSION
•	Smaller an adrenocortical carcinoma at the time of diagnosis, the lower the tumor stage and the better the overall
prognosis.
•	Adrenal carcinomas are extremely aggressive and are invariably fatal if not diagnosed early. They have tendency to
attain massive size as in our patient and causes significant debilitation.
•	All adrenal incidentalomas especially in young age group require an immediate and an optimal diagnostic approach
to rule out malignancy or secretory function, close biochemical and radiographic follow up.
•	Adrenalectomy should be a consideration in the presence of autonomous hormonal secretion or if the mass
enlarges by 1 cm or more during the period of observation.1
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Figure A: Right adrenal incidentaloma measuring 3cm x 2.6cm x 3cm.
Figure B: Heterogeneously enhancing mass in the right adrenal fossa
increased in size to 8.9cmx9.1cmx6cm.

Figure C and D: Adrenal cortical carcinoma measuring
27cmx15cmx 11cm occupying the entire hemi-abdomen abutting the
liver, extending into retroperitoneum, compressing the inferior vena
cava and encasing the renal vein.
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